A statement of changes in beneficial ownership was filed on November 2, 2026, reporting that Steven Love, a director of OmniAb, Inc. (NASDAQ:OABI), received 13,334 shares of common stock through the vesting of restricted stock units on November 1, 2026.

Key Highlights

  • Reporting person: Steven Love, identified as a director of OmniAb, Inc.
  • Transaction date: November 1, 2026, with the filing submitted on November 2, 2026.
  • Shares acquired: 13,334 shares of common stock acquired via an RSU vesting event, coded as transaction type "M."
  • Post-transaction holdings: Steven Love directly owns 105,000 shares of OmniAb common stock following the transaction.
  • Remaining derivative securities: 20,000 restricted stock units remain beneficially owned directly after the reported transaction.
  • RSU price: The price of the derivative security (restricted stock units) is listed as $0, according to the filing.

Steven Love's RSU Vesting and Ownership Position at OmniAb

According to the filing, the 13,334 shares acquired by Steven Love represent one installment of a restricted stock unit award that vests "in three substantially equal annual installments, beginning November 1st, 2024, subject to the Reporting Person's continued service to the Issuer through each such vesting date." OmniAb, Inc. is a biotechnology company that operates in the antibody discovery space, and its common stock trades on NASDAQ under the ticker OABI.

The filing further explains that each restricted stock unit represents "a contingent right to receive one share of the Issuer's Common Stock." Prior to the vesting event, the RSU holding in Table II reflected 13,334 units being disposed of through the "M" transaction code, consistent with the conversion of derivative securities into shares. Following the transaction, Love holds 20,000 restricted stock units directly, in addition to his 105,000 directly held common shares. The filing was signed by Charles S. Berkman as attorney-in-fact for Steven Love.

What Was Disclosed

The filing disclosed that OmniAb director Steven Love acquired 13,334 shares of common stock on November 1, 2026, through RSU vesting, bringing his direct common stock holdings to 105,000 shares, with 20,000 RSUs remaining outstanding.